US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist

1.0500
+0.0400+3.96%

Close Nov 22 16:00 ET

1.0999
+0.0499+4.75%

Post 20:01 ET

193.68MMarket Cap-1250P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-4.30%-43.93M

26.82%-37.7M

7.76%-47.89M

36.64%-192.61M

18.47%-47.05M

49.18%-42.12M

31.30%-51.52M

41.29%-51.92M

26.33%-304.01M

61.92%-57.7M

Net income from continuing operations

19.15%-37.06M

-2.43%-52.36M

73.14%-36.8M

25.03%-276.06M

29.50%-42.08M

22.37%-45.84M

67.86%-51.12M

-51.58%-137.02M

29.71%-368.2M

59.02%-59.69M

Operating gains losses

----

117.41%6.4M

----

-558.10%-36.75M

-968.41%-3.33M

Depreciation and amortization

-41.42%993K

-32.64%1.46M

-30.19%1.61M

-40.02%7.82M

-48.08%1.65M

-36.68%1.7M

-37.05%2.17M

-38.28%2.3M

-7.89%13.03M

-7.39%3.18M

Deferred tax

-106.67%-31K

311.11%57K

97.90%-38K

-105.17%-140K

-36.71%1.71M

---15K

---27K

---1.81M

2,754.90%2.71M

--2.71M

Other non cash items

20.77%-9.71M

-11.72%-7.32M

4.01%-13.04M

-21.30%-43.59M

-7.37%-11.19M

-1.39%-12.26M

31.85%-6.55M

-257.03%-13.59M

-436.44%-35.93M

-180.28%-10.43M

Change In working capital

133.83%1.09M

215.42%10.8M

-167.62%-6.62M

-4,124.39%-19.8M

41.35%-4.73M

88.36%-3.23M

-142.89%-9.36M

-117.05%-2.47M

102.14%492K

84.40%-8.07M

-Change in receivables

2.19%-850K

45.84%2.42M

-180.78%-2.41M

-71.07%4.78M

-82.00%999K

43.05%-869K

-91.79%1.66M

138.64%2.99M

33.19%16.51M

121.86%5.55M

-Change in inventory

-94.80%123K

128.12%212K

42.42%-1.14M

120.55%699K

838.62%1.07M

213.36%2.37M

52.58%-754K

-570.38%-1.99M

-568.17%-3.4M

69.21%-145K

-Change in payables and accrued expense

716.19%8.82M

162.14%6.62M

111.92%868K

-18.78%-20.01M

77.82%-3.16M

105.85%1.08M

-742.25%-10.65M

-142.41%-7.28M

51.34%-16.84M

54.61%-14.26M

-Change in other current assets

-3.65%-3.58M

20.86%2.79M

-117.46%-976K

-48.12%3.58M

-142.40%-867K

-24.80%-3.45M

-51.48%2.31M

95.22%5.59M

367.05%6.91M

160.15%2.05M

-Change in other working capital

-45.02%-3.42M

35.89%-1.24M

-65.62%-2.96M

-230.22%-8.85M

-120.53%-2.77M

18.84%-2.36M

-541.53%-1.93M

-199.94%-1.79M

-214.53%-2.68M

93.36%-1.26M

Cash from discontinued investing activities

Operating cash flow

-4.30%-43.93M

26.82%-37.7M

7.76%-47.89M

36.64%-192.61M

18.47%-47.05M

49.18%-42.12M

31.30%-51.52M

41.29%-51.92M

26.33%-304.01M

61.92%-57.7M

Investing cash flow

Cash flow from continuing investing activities

-18.25%46.12M

-32.53%16.98M

-52.56%19.26M

-61.85%139.56M

-56.56%17.38M

-49.36%56.41M

-70.09%25.17M

-68.84%40.6M

80.41%365.84M

-66.71%40.01M

Net PPE purchase and sale

-154.95%-666K

-14.81%-186K

63.74%-157K

-94.95%380K

-101.87%-237K

769.61%1.21M

79.23%-162K

89.70%-433K

150.17%7.52M

315.13%12.68M

Net investment purchase and sale

-15.25%46.78M

-32.23%17.17M

-52.68%19.42M

-61.16%139.18M

-35.53%17.62M

-50.53%55.2M

-70.17%25.33M

-69.49%41.03M

64.54%358.32M

-78.33%27.33M

Cash from discontinued investing activities

Investing cash flow

-18.25%46.12M

-32.53%16.98M

-52.56%19.26M

-61.85%139.56M

-56.56%17.38M

-49.36%56.41M

-70.09%25.17M

-68.84%40.6M

80.41%365.84M

-66.71%40.01M

Financing cash flow

Cash flow from continuing financing activities

13K

5.56%19K

42M

-98.01%30K

-88.35%12K

-96.15%18K

-95.84%1.51M

-95.96%103K

Net common stock issuance

--0

---3M

----

--0

----

Proceeds from stock option exercised by employees

--13K

5.56%19K

--30M

-96.04%30K

-88.35%12K

--0

-96.15%18K

--0

-97.72%758K

-94.28%103K

Net other financing activities

--0

--15M

----

-75.00%750K

--0

Cash from discontinued financing activities

Financing cash flow

--13K

5.56%19K

--42M

-98.01%30K

-88.35%12K

--0

-96.15%18K

--0

-95.84%1.51M

-95.96%103K

Net cash flow

Beginning cash position

-44.92%27.94M

-36.79%48.64M

-60.02%35.28M

249.86%88.23M

-38.61%64.92M

-34.58%50.73M

13.18%76.96M

249.86%88.23M

-87.32%25.22M

95.79%105.76M

Current changes in cash

-84.63%2.2M

21.39%-20.7M

218.17%13.37M

-183.70%-53.01M

-68.61%-29.65M

-49.87%14.29M

-373.69%-26.33M

-126.45%-11.32M

136.47%63.34M

38.91%-17.59M

Effect of exchange rate changes

71.43%-28K

-100.93%-1K

-117.78%-8K

118.96%62K

-85.45%8K

66.78%-98K

252.86%107K

364.71%45K

-255.43%-327K

650.00%55K

End cash Position

-53.62%30.11M

-44.92%27.94M

-36.79%48.64M

-60.02%35.28M

-38.61%64.92M

-34.58%50.73M

13.18%76.96M

249.86%88.23M

Free cash flow

-5.80%-44.6M

26.69%-37.89M

8.22%-48.05M

37.53%-193.47M

18.78%-47.28M

49.25%-42.15M

31.79%-51.69M

43.49%-52.35M

27.58%-309.68M

63.02%-58.22M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-4.30%-43.93M	26.82%-37.7M	7.76%-47.89M	36.64%-192.61M	18.47%-47.05M	49.18%-42.12M	31.30%-51.52M	41.29%-51.92M	26.33%-304.01M	61.92%-57.7M
Net income from continuing operations	19.15%-37.06M	-2.43%-52.36M	73.14%-36.8M	25.03%-276.06M	29.50%-42.08M	22.37%-45.84M	67.86%-51.12M	-51.58%-137.02M	29.71%-368.2M	59.02%-59.69M
Operating gains losses	----	----	----	117.41%6.4M	----	----	----	----	-558.10%-36.75M	-968.41%-3.33M
Depreciation and amortization	-41.42%993K	-32.64%1.46M	-30.19%1.61M	-40.02%7.82M	-48.08%1.65M	-36.68%1.7M	-37.05%2.17M	-38.28%2.3M	-7.89%13.03M	-7.39%3.18M
Deferred tax	-106.67%-31K	311.11%57K	97.90%-38K	-105.17%-140K	-36.71%1.71M	---15K	---27K	---1.81M	2,754.90%2.71M	--2.71M
Other non cash items	20.77%-9.71M	-11.72%-7.32M	4.01%-13.04M	-21.30%-43.59M	-7.37%-11.19M	-1.39%-12.26M	31.85%-6.55M	-257.03%-13.59M	-436.44%-35.93M	-180.28%-10.43M
Change In working capital	133.83%1.09M	215.42%10.8M	-167.62%-6.62M	-4,124.39%-19.8M	41.35%-4.73M	88.36%-3.23M	-142.89%-9.36M	-117.05%-2.47M	102.14%492K	84.40%-8.07M
-Change in receivables	2.19%-850K	45.84%2.42M	-180.78%-2.41M	-71.07%4.78M	-82.00%999K	43.05%-869K	-91.79%1.66M	138.64%2.99M	33.19%16.51M	121.86%5.55M
-Change in inventory	-94.80%123K	128.12%212K	42.42%-1.14M	120.55%699K	838.62%1.07M	213.36%2.37M	52.58%-754K	-570.38%-1.99M	-568.17%-3.4M	69.21%-145K
-Change in payables and accrued expense	716.19%8.82M	162.14%6.62M	111.92%868K	-18.78%-20.01M	77.82%-3.16M	105.85%1.08M	-742.25%-10.65M	-142.41%-7.28M	51.34%-16.84M	54.61%-14.26M
-Change in other current assets	-3.65%-3.58M	20.86%2.79M	-117.46%-976K	-48.12%3.58M	-142.40%-867K	-24.80%-3.45M	-51.48%2.31M	95.22%5.59M	367.05%6.91M	160.15%2.05M
-Change in other working capital	-45.02%-3.42M	35.89%-1.24M	-65.62%-2.96M	-230.22%-8.85M	-120.53%-2.77M	18.84%-2.36M	-541.53%-1.93M	-199.94%-1.79M	-214.53%-2.68M	93.36%-1.26M
Cash from discontinued investing activities
Operating cash flow	-4.30%-43.93M	26.82%-37.7M	7.76%-47.89M	36.64%-192.61M	18.47%-47.05M	49.18%-42.12M	31.30%-51.52M	41.29%-51.92M	26.33%-304.01M	61.92%-57.7M
Investing cash flow
Cash flow from continuing investing activities	-18.25%46.12M	-32.53%16.98M	-52.56%19.26M	-61.85%139.56M	-56.56%17.38M	-49.36%56.41M	-70.09%25.17M	-68.84%40.6M	80.41%365.84M	-66.71%40.01M
Net PPE purchase and sale	-154.95%-666K	-14.81%-186K	63.74%-157K	-94.95%380K	-101.87%-237K	769.61%1.21M	79.23%-162K	89.70%-433K	150.17%7.52M	315.13%12.68M
Net investment purchase and sale	-15.25%46.78M	-32.23%17.17M	-52.68%19.42M	-61.16%139.18M	-35.53%17.62M	-50.53%55.2M	-70.17%25.33M	-69.49%41.03M	64.54%358.32M	-78.33%27.33M
Cash from discontinued investing activities
Investing cash flow	-18.25%46.12M	-32.53%16.98M	-52.56%19.26M	-61.85%139.56M	-56.56%17.38M	-49.36%56.41M	-70.09%25.17M	-68.84%40.6M	80.41%365.84M	-66.71%40.01M
Financing cash flow
Cash flow from continuing financing activities	13K	5.56%19K	42M	-98.01%30K	-88.35%12K	0	-96.15%18K	0	-95.84%1.51M	-95.96%103K
Net common stock issuance	--0	--0	---3M	----	----	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	--13K	5.56%19K	--30M	-96.04%30K	-88.35%12K	--0	-96.15%18K	--0	-97.72%758K	-94.28%103K
Net other financing activities	--0	--0	--15M	----	----	----	----	----	-75.00%750K	--0
Cash from discontinued financing activities
Financing cash flow	--13K	5.56%19K	--42M	-98.01%30K	-88.35%12K	--0	-96.15%18K	--0	-95.84%1.51M	-95.96%103K
Net cash flow
Beginning cash position	-44.92%27.94M	-36.79%48.64M	-60.02%35.28M	249.86%88.23M	-38.61%64.92M	-34.58%50.73M	13.18%76.96M	249.86%88.23M	-87.32%25.22M	95.79%105.76M
Current changes in cash	-84.63%2.2M	21.39%-20.7M	218.17%13.37M	-183.70%-53.01M	-68.61%-29.65M	-49.87%14.29M	-373.69%-26.33M	-126.45%-11.32M	136.47%63.34M	38.91%-17.59M
Effect of exchange rate changes	71.43%-28K	-100.93%-1K	-117.78%-8K	118.96%62K	-85.45%8K	66.78%-98K	252.86%107K	364.71%45K	-255.43%-327K	650.00%55K
End cash Position	-53.62%30.11M	-44.92%27.94M	-36.79%48.64M	-60.02%35.28M	-60.02%35.28M	-38.61%64.92M	-34.58%50.73M	13.18%76.96M	249.86%88.23M	249.86%88.23M
Free cash flow	-5.80%-44.6M	26.69%-37.89M	8.22%-48.05M	37.53%-193.47M	18.78%-47.28M	49.25%-42.15M	31.79%-51.69M	43.49%-52.35M	27.58%-309.68M	63.02%-58.22M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data